Cancer, ivermectin thalidomide and vit D

Summary

The transcript discusses the efficacy and safety of ivermectin and its potential applications beyond its current use, including anti-cancer properties. The speaker highlights personal experiences where ivermectin helped severely ill patients, arguing against government restrictions on its use. Additionally, the conversation explores the importance of vitamin D levels in cancer treatment, noting that low levels correlate with poor responses to chemotherapy. The discussion emphasizes the need for integrating these treatments into standard care, advocating for a more holistic approach to patient health that includes readily available and safe interventions.

Takeaways

• 😀 Ivermectin has shown effectiveness in treating COVID-19, particularly in very ill patients, contrary to government claims of toxicity.
• 😀 Ivermectin is considered one of the safest drugs, with lower toxicity than common medications like ibuprofen and paracetamol.
• 😀 Research indicates that Ivermectin may possess antiviral and potential anti-cancer properties, similar to the drug lenalidomide.
• 😀 Lenalidomide has been established as a primary treatment for certain cancers and has demonstrated significant efficacy in clinical settings.
• 😀 Both Ivermectin and lenalidomide target multiple biological pathways, which may contribute to their therapeutic effects at non-toxic doses.
• 😀 The combination of Ivermectin or lenalidomide with conventional cancer treatments could enhance the overall effectiveness of the therapy.
• 😀 Maintaining adequate vitamin D levels is crucial for the effectiveness of cancer treatments and immune therapies.
• 😀 Research has shown that patients with low vitamin D levels are less likely to respond to chemotherapy, highlighting the need for regular vitamin D testing.
• 😀 There is a call for improved awareness and testing of vitamin D levels in cancer treatment protocols across healthcare settings.
• 😀 The discussion emphasizes the importance of integrating natural therapies, such as vitamin D supplementation, with medical treatments for better health outcomes.

Q & A

What is the speaker's experience with Ivermectin in treating critically ill patients?

The speaker has personally used Ivermectin on two critically ill patients who did not want to go to the hospital, and both patients responded positively to the treatment.

How does the speaker compare the safety of Ivermectin to other common medications?

The speaker claims that Ivermectin has a much lower toxicity than Ibuprofen or Paracetamol, suggesting it is one of the world's safest drugs.

What potential benefits of Ivermectin are mentioned beyond treating COVID-19?

The speaker mentions potential antiviral and anti-cancer properties of Ivermectin, citing research that suggests it could have significant therapeutic effects.

What challenges did the speaker face in conducting research on Ivermectin?

The speaker's applications for research funding were turned down by major funding bodies due to concerns about Ivermectin's historical association with birth defects, even though they believed its benefits outweighed these concerns.

What role does Vitamin D play in cancer treatment, according to the speaker?

The speaker emphasizes that adequate Vitamin D levels are crucial for the effectiveness of chemotherapy, noting that patients with low Vitamin D levels often do not respond to standard treatments.

What specific Vitamin D levels does the speaker recommend for optimal treatment outcomes?

The speaker recommends achieving Vitamin D levels over 100 nanomoles per liter, which is higher than the NHS's normal range of 50 nanomoles per liter.

How does the speaker view the current medical community's approach to Vitamin D supplementation?

The speaker criticizes the medical community for not routinely measuring and addressing Vitamin D levels in cancer patients, despite evidence linking low Vitamin D to treatment failures.

What is the relationship between Ivermectin and lenalidomide mentioned in the transcript?

The speaker notes that Ivermectin and lenalidomide have similar mechanisms of action, both affecting multiple pathways, which may allow them to be administered safely at non-toxic doses with anti-cancer activity.

What is the significance of the speaker's reference to the research on Vitamin D levels in cancer patients?

The speaker refers to a study where patients with high Vitamin D levels had better responses to chemotherapy, reinforcing the importance of maintaining adequate Vitamin D in cancer treatment protocols.

What is the speaker's overall message regarding the integration of Ivermectin and Vitamin D into treatment protocols?

The speaker advocates for the incorporation of Ivermectin and Vitamin D supplementation into standard medical practices to enhance treatment effectiveness and improve patient outcomes.